T5601640
-
Catalog numberB1097-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_name3-Methyl-N-[3-[[[3-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-5-isoxazolecarboxamide; T56-LIMKi
-
DescriptionT5601640, also known as T56-LIMKi, has high specific inhibitory activity for LIMK2 and shows little or no activity with LIMK1. It decreases levels of phosphorylated coflin (p-coflin) inhibiting several cancer cell lines including those of pancreatic cancer, gliomas and schwannoma.
-
CAS Number924473-59-6
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₁₉H₁₄F₃N₃O₃
-
Molecular Weight389.33
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>15 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA specific LIMK2 inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberNFCD08495674
-
PubChem CID9438169
-
SMILESCC1=NOC(=C1)C(=O)NC2=CC=CC(=C2)C(=O)NC3=CC=CC(=C3)C(F)(F)F
-
InChiInChI=1S/C19H14F3N3O3/c1-11-8-16(28-25-11)18(27)24-14-6-2-4-12(9-14)17(26)23-15-7-3-5-13(10-15)19(20,21)22/h2-10H,1H3,(H,23,26)(H,24,27)
-
InChi KeyXVOKFRPKSAWELK-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameT5601640
-
Alternative nameT5601640
-